dmeph | 12228
Dexmethylphenidat + Ritalin
Keywords:
(2R 2'R)-methylphenidate
D-(+)-methylphenidate
D-threo-methylphenidate
Dexmethylphenidate
Focalin
d-TMP
Status
| Material |
|
||
|---|---|---|---|
| Hint |
Indicated reference ranges refer to peak levels. Blood should be taken 4 hours following an oral dose of the drug. | Immediately centrifuge the tube after coagulation. | Separate serum. | Freeze serum | Protect from light. |
||
| Min. volume | 200 µL | ||
| Stability |
Stability
2 weeks / -20°C
|
||
| Duration | 4 days | ||
| Frequency | 2 x per week (monday, thursday) | ||
| Method | Liquid chromatography / mass spectrometry (LCMS) |
Price/Rate
| Price |
Price
CHF 252.00
|
|---|---|
| Rate |
Rate
252.00 TP
|
Single Analysis
| Dexmethylphenidate | dmeph0 | Serum protected from light and frozen |
|---|---|---|
| Ritalic acid | rita0 | Serum protected from light and frozen |
| Ritalic acid | rita1 | Serum protected from light and frozen |
| Dexmethylphenidate | dmeph1 | Serum protected from light and frozen |
